A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, February 23 | 2-3 p.m. ET | Bethesda, MD & Online The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers […]
Thursday, February 23 | 7-8 p.m. ET | Washington, DC The National Museum of African American History and Culture (NMAAHC) presents the third in a series of four discussions organized […]
Monday, February 27 | 9 a.m.-4:45 p.m. ET | Online The U.S. Food and Drug Administration (FDA) will host Rare Disease Day, a virtual public meeting, on February 27, in […]
Wednesday, March 1 | 8-9:30 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
March 2-3 | Virtual & Orlando, FL The University of Florida College of Pharmacy has partnered with GenomeWeb's Precision Medicine Leaders’ Summit to produce this event, which will be in-person […]
Thursday, March 2 | 8-9:30 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
Monday, March 6 - Tuesday, March 7 | Washington, DC & Virtual Innovations in the diagnostic specialties have the potential to dramatically reshape cancer diagnosis and enable precision therapy. Spurred […]
Tuesday, March 7 | 8-9 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
Wednesday, March 8 | 8-10 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
Thursday, March 9 | 8-9 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
GMKB